Published in Cancer Weekly, May 28th, 2002
"T-cell prolymphocytic leukemia (T-PLL) is a rare form of mature T-cell leukemia that is generally resistant to conventional chemotherapy," explained Dr. Christian Recher and colleagues at Saint Louis Hospital and Fernand Widal Hospital in Paris.
Animals suffering from this form of malignancy showed positive responses to ATO treatment, the researchers found.
Recher and coauthors studied mice engineered to carry the oncogene MTCP1,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.